eJHaem is a Gold Open Access (OA), sound science journal of the British Society for Haematology and Wiley publishing haematology practice and research applicable to a worldwide readership.
We offer rapid publication and fast decision times with an average of 7 days to first decision. By publishing OA, your research will be free to read and share, with author copyright retention. Indexed in major databases like PubMed and Web of Science, we offer greater reach to your OA research.
We accept direct submissions as well as content that is cascaded from the top quartile journals the British Journal of Haematology and the American Journal of Hematology.
Journal Metrics
- 1.2Journal Impact Factor
- 52%Acceptance rate
- 24 days Submission to first decision
Reasons to Publish with Us:
- Experience fast decision times with an average of 11 days to first decision, and 26 days to final decision.
- An official BSH journal, supported by the BJHaem, a top 15% JCR-ranked Haematology journal.
- Open access format makes your research free to read and share, with author copyright retention.
- Create impact faster with quick publishing via an electronic-only format.
Review our Author Guidelines and submit your manuscript.
Publishing Open Access? Your fees may be covered... check now.
Your APC may be covered
Wiley has a range of agreements with funders and institutions that may provide funding for your paper. Find out more here - Institutional Payments | Wiley
In some countries waivers or partial waivers may be available. Find out more here – Open Access Waivers and Discounts | Wiley
If you have any questions about your APC, please contact [email protected].
Meet the Editor-In-Chief
Dr. Phil Scheinberg
Dr. Phil Scheinberg is Chief of Hematology at the Hospital A Beneficência Portuguesa de São Paulo in Brazil and has served as Associate Editor for BJHaem since 2019. His primary research focus is on bone marrow failure syndromes. He is widely published in high-profile journals and has developed new treatment paradigms and uncovered key insights into the pathophysiology of these disorders.
Meet the Associate Editor
Professor Michael F. Murphy - Transfusion
Professor of Transfusion Medicine at the University of Oxford and Consultant Haematologist for NHS Blood & Transplant (NHSBT) and Oxford University Hospitals NHS Foundation Trust.
Find out more here.
Meet the Associate Editor
Dr. Jessica Okosun, Associate Editor – Lymphomas
Dr. Jessica Okosun is a Cancer Research UK at the Barts Cancer Institute and a Consultant Haematologist at St. Bartholomew’s Hospital, London UK, specialising in lymphomas.
Find out more here.
Meet the Associate Editor
Prof. Christian Recher, Associate Editor – AML
Prof. Christian Recher is Head of the Haematology Department at Toulouse-Oncopole Cancer University Institute in France.
Find out more here.
Meet the Associate Editor
Francesco Rodeghiero, Associate Editor - Benign Haematology
Dr. Rodeghiero is currently the Scientific Director of the Hematology Project Foundation, and previously directed the Haematology Department of the San Bortolo Hospital in Vicenza.
Find out more here.
Meet the Associate Editor
Deborah Rund
Senior hematologist, morphology specialist, and Director of Therapeutic Apheresis at Hadassah University Hospital.
Find out more here.
Meet the Associate Editor
Professor Eliza Hawkes, Associate Editor – Lymphomas
A/Prof Hawkes is a medical oncologist and lymphoma lead at the Olivia Newton John Cancer Research & Wellness Centre, Austin Health, a National Health and Medical Research Council Investigator, Associate Professor at Monash University in Melbourne Australia. Find out more here.
Meet the Associate Editor
Katja Christina Weisel, MD, Associate Editor - Myelomas
Katja Christina Weisel, MD is Deputy Director and associate professor of Haematology/Oncology at the University Medical Center Hamburg-Eppendorf, Germany.
Find out more here.
Articles
Prognostic Value of Geriatric Characteristics in Allogeneic Haematopoietic Stem Cell Transplant Recipients Aged Over 60 Years
- 1 August 2025
Comprehensive Genetic Analysis of Central Nervous System Involvement in Mycosis Fungoides: A Case Report
- 1 August 2025
Rapid Identification of DUX4::IGH Fusion in Acute Lymphoblastic Leukemia
- 28 July 2025
Intersecting Anemias: PARP Inhibitor‐Induced Toxicity and Autoimmune Hemolysis—A Case Report
- 28 July 2025
Physician Survey on the Management of Pulmonary Embolism in Pregnancy: Need for Guidance and Training
- 28 July 2025
The Intersection of Lynch Syndrome and Hematological Malignancies: A Rare Short Report
- 28 July 2025
A Confusing Case of Confusion: Bing–Neel Syndrome Treated With Zanubrutinib
- 25 July 2025
Safety, Efficacy, and Patient‐Reported Outcomes From a Phase 2 Randomized Trial of Pozelimab and Cemdisiran Combination in Patients With Paroxysmal Nocturnal Hemoglobinuria
- 24 July 2025
Multicenter Single‐Blind Randomized Controlled Trial of the Romiplostim Biosimilar
- 24 July 2025
Prompt Autologous Hematopoietic Stem Cell Transplant in Patients With Large B‐Cell Lymphoma Is Associated With Lower Rates of Progression of Disease Prior to Transplant
- 24 July 2025
Latest news
Sign up for email alerts
Tools
The Official Journal of the British Society for Haematology
Related Title
The BSH Guidelines Official Podcast
Written by expert consultants and clinical scientists currently practising in the UK, the BSH Guidelines provide up-to-date evidence-based guidance on the diagnosis and treatment of haematological diseases.Click here to listen to the podcast's full library